Abstract: Key classes have become excellent starting points for developers to understand unknown software systems. Up to now, a variety of approaches have been proposed to mine key classes in a ...
President Trump on Monday announced plans to build a new fleet of Navy battleships, anchoring what he called the Pentagon's "Golden Fleet." The president said he approved plans to begin constructing ...
NEW YORK, Dec. 1, 2025 /PRNewswire/ -- OncoPrecision Corporation ("OncoPrecision"), a translational therapeutics company developing novel antibody-based cancer therapies informed by large-scale ...
For more information about the SITC Annual Meeting, please visit sitcancer.org. About AIM ImmunoTech Inc. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of ...
Oral presentation will highlight the results from the randomized Phase 3 trial (IOB-013/KN-D18) of IO102-IO103 cancer vaccine plus pembrolizumab for first-line (1L) advanced melanoma Poster ...
KT-621 BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) patients on track to report data in 4Q25 KT-621 Phase 2b trials in AD and asthma on track to initiate in 4Q25 and 1Q26, ...
A Texas state representative is speaking out after a Texas A&M student was allegedly removed from a class for questioning transgender-related course content. “After serving under President Trump, I ...
Have you ever wondered how Java seamlessly combines its primitive data types with object-oriented programming? Enter wrapper classes, an important but often overlooked Java feature. These special ...
When one accesses the getExtensions() method of an abstract class that implements ExtensionAware a java.lang.NoSuchMethodError is thrown. The conditions for this to ...
TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer. TScan Therapeutics, Inc., a clinical-stage biotechnology ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), an oncology company developing innovative, full-length ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results